Literature DB >> 26769993

Prevention of neural tube defects by the fortification of flour with folic acid: a population-based retrospective study in Brazil.

Leonor Maria Pacheco Santos1, Roberto Carlos Reyes Lecca2, Juan Jose Cortez-Escalante3, Mauro Niskier Sanchez1, Humberto Gabriel Rodrigues4.   

Abstract

OBJECTIVE: To determine if the fortification of wheat and maize flours with iron and folic acid - which became mandatory in Brazil from June 2004 - is effective in the prevention of neural tube defects.
METHODS: Using data from national information systems on births in central, south-eastern and southern Brazil, we determined the prevalence of neural tube defects among live births and stillbirths in a pre-fortification period - i.e. 2001-2004 - and in a post-fortification period - i.e. 2005-2014. We distinguished between anencephaly, encephalocele, meningocele, myelomeningocele and other forms of spina bifida.
FINDINGS: There were 8554 neural tube defects for 17,925,729 live births notified between 2001 and 2014. For the same period, 2673 neural tube defects were reported for 194,858 stillbirths. The overall prevalence of neural tube defects fell from 0.79 per 1000 pre-fortification to 0.55 per 1000 post-fortification (prevalence ratio, PR: 1.43; 95% confidence interval, CI: 1.38-1.50). For stillbirths, prevalence fell from 17.74 per 1000 stillbirths pre-fortification to 11.70 per 1000 stillbirths post-fortification. The corresponding values among live births were 0.57 and 0.44, respectively.
CONCLUSION: The introduction of the mandatory fortification of flour with iron and folic acid in Brazil was followed by a significant reduction in the prevalence of neural tube defects in our study area.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26769993      PMCID: PMC4709794          DOI: 10.2471/BLT.14.151365

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


Introduction

Neural tube defects, which are detected in about 300 000 neonates worldwide each year, are a major cause of neonatal morbidity and mortality. They are caused by the abnormal closure of the embryonic neural tube between 22 and 28 days after conception. The resulting structural defects, which may occur anywhere along the neuraxis, often lead to the postpartum exposure of neural tissue and this, in turn, may lead to severe impairment in the child’s physical and mental development., Classically, neural tube defects are divided into two main groups: defects affecting brain structures – such as anencephaly and encephalocele and defects that affect the structures of the spinal cord – such as meningocele, myelomeningocele and other forms of spina bifida., Anencephaly – also called exencephaly or craniorachischisis – is defined as the complete or partial absence of the brain. This defect, which is caused by a failure of the cephalic neural tube to close,, leads to fetal deaths, stillbirths or neonatal deaths. In encephalocele, the brain and meninges herniate through a skull defect, especially in the occipital region. Spina bifida is characterized by the failure of fusion of the vertebral arches of the spine. This defect can be covered by skin – when it is known as spina bifida occulta – or be associated with a cystic protrusion. In meningocele, this protrusion contains abnormal meninges and cerebrospinal fluid. In myelomeningocele, the cystic protrusion contains elements of the spinal cord and/or nerves. Neural tube defects have been associated with both genetic factors – e.g. simple gene mutations and chromosomal abnormalities – and maternal factors such as folate intake, age, ethnicity, obesity and the use of antiepileptic drugs. If maternal intake of folic acid can be increased around the time of conception, the risk of the occurrence of neural tube defects may be reduced by 60–70%.– This preventive strategy has been adopted by 78 countries that have mandated the addition of folic acid to flour. Such folic acid fortification has already been associated with reductions in the prevalence of neural tube defects in Canada, Chile, South Africa and the United States of America (USA). In 2002, Brazil’s Health Surveillance Agency made the fortification of wheat and maize flour with iron and folic acid mandatory in the country from June 2004 – allowing flour producers more than a year to adapt to the new legislation All wheat and maize flour sold in Brazil since June 2004 should contain 0.15 mg folic acid per 100 g. Although most studies on the prevalence of neural tube defects have been focused on live births, the prevalence of such defects among miscarriages and stillbirths may be higher than that among live births. In the United Kingdom of Great Britain and Northern Ireland, for example, such defects were detected in 2.8/1000 live births and 5.3/1000 miscarriages at eight weeks of gestation. In Northern Ireland and south-east England neural tube defects were 7.1/1000 in live births and 10.8 /1000 in eight-week miscarriages. In this population-based retrospective study, we aimed to determine if the mandatory addition of folic acid to flour sold in Brazil was associated with a change in the prevalence of neural tube defects in live and stillbirths.

Methods

Databases

We analysed data that had been routinely collected, in central, south-eastern and southern Brazil, by the national ministry of health and recorded within either the live birth information system database – i.e. as live births – or the mortality information system database – i.e. as stillbirths. The live birth database was introduced in 1990 but has only included notification of congenital anomalies since 1999. Between 1999 and 2006, only one of the codes of the International classification of diseases and related health problems (ICD) could be entered in this database per birth. Since 2007, however, it has been possible to enter multiple codes to cover all of the congenital anomalies present in a child.

Study design

We compared the prevalence of neural tube defects among live births and stillbirths in the pre-fortification period – i.e. 2001–2004 – with that recorded in the post-fortification period – i.e. 2005–2014. In our analyses, we assumed that all children born in 2004 would have been conceived before fortification became mandatory in June 2004. We therefore considered the whole year of 2004 to be pre-fortification.

Defect prevalence

We identified as neural tube defects all anomalies coded Q00, Q01 or Q05 according to the ICD, tenth revision, indicative of anencephaly, encephalocele and all forms of spina bifida, respectively. We only analysed data from the states of central, south-eastern and southern Brazil in which the proportion of all births registered in either the live birth database or the mortality database was estimated to exceed 95%., The eight states we included were the central states of Distrito Federal and Mato Grosso do Sul, the south-eastern states of Espírito Santo, Rio de Janeiro and São Paulo and the southern states of Paraná, Rio Grande do Sul and Santa Catarina.

Study variables

In our analysis we used flour fortification as the independent variable, the presence of at least one neural tube defect as the dependent variable, and maternal age, sex of the neonate or stillborn child and race of the neonate as the predictors. If no information on outcome of a birth had been recorded – i.e. if it was possible that a neural tube defect had been detected but not recorded – that birth was excluded from our analyses (Fig. 1). Maternal age was categorized into three age groups: younger than 20, 20 to 34 and older than 34 years – representing adolescents, young adults and older mothers, respectively. Neonatal race was recorded in the live birth database as black, brown, indigenous or white. No information on stillbirth race was available from the mortality database. The data available on maternal age and sex of the neonates or stillbirths were incomplete.
Fig. 1

Flowchart for the selection of birth records from the national live birth information and mortality information systems, Brazil, 2001–2014

Flowchart for the selection of birth records from the national live birth information and mortality information systems, Brazil, 2001–2014

Data analysis

Data were exported and analysed using Epi Info version 7.0 (Centers for Disease Control and Prevention, Atlanta, USA) and Origin 6.0 (Microcal Software, Northampton, USA). The prevalence of any neural tube defect and of defect subtypes coded Q00, Q01 and Q05 were each estimated for the pre-fortification and post-fortification periods. The ratio between each pre-fortification prevalence and the corresponding post-fortification value – and the relevant 95% confidence interval (CI) – was calculated.

Ethics

The study protocol was approved by the ethics committee of the Universidade Estadual de Montes Claros, Montes Claros, Minas Gerais, Brazil.

Results

We investigated the records of 19 045 161 live births from the live births database and the records of 194 858 stillbirths from the mortality database. All of the births we investigated occurred between 1 January 2001 and 31 December 2014 and together they represented 45.5% of the total (42 285 756) birth records in Brazil for that period. The 17 925 729 valid cases of live births and 194 858 stillbirths used in our analyses included 8554 and 2673 cases of neural tube defects, respectively (Fig. 1). Table 1 summarizes the prevalence of neural tube defects recorded among all live births and stillbirths. In the pre-fortification period, the prevalence of such defects among all births – i.e. live births and stillbirths combined – was 0.79 per 1000 births. The corresponding post-fortification value was 30.1% lower, at 0.55 per 1000 births. Among the live births, the prevalence of neural tube defects was 22.8% lower post-fortification than pre-fortification: 0.44 versus 0.57 per 1000 live births. Among stillbirths, the prevalence was 34.0% lower post-fortification than pre-fortification: 11.70 versus 17.74 per 1000 stillbirths.
Table 1

Prevalence of neural tube defects before and after the mandatory fortification of flours with folic acid, Brazil, 2001–2014

TypeNo. of births investigatedNo. of births with NTDPrevalence
NTD per 1000 birthsRatio (95% CI)Change, %
Live births
Pre-fortificationa4 938 3432 8230.571.29 (1.24–1.35)−22.8
Post-fortificationb12 987 3865 7310.441
Total17 925 7298 554
Stillbirths
Pre-fortificationa65 1211 15517.741.52 (1.40–1.63)−34.0
Post-fortificationb129 7371 51811.701
Total194 8582 673
All births
Pre-fortificationa5 003 4643 9780.791.43 (1.38–1.50)−30.1
Post-fortificationb13 117 1237 2490.551
Total18 120 58711 227

CI: confidence interval; NTD: neural tube defect.

a The pre-fortification study period ran from 1 January 2001 to 31 December 2004 – although fortification became mandatory in June 2014.

b The post-fortification study period, which ran from 1 January 2005 to 31 December 2014, was used as the reference category in the calculation of prevalence ratios.

CI: confidence interval; NTD: neural tube defect. a The pre-fortification study period ran from 1 January 2001 to 31 December 2004 – although fortification became mandatory in June 2014. b The post-fortification study period, which ran from 1 January 2005 to 31 December 2014, was used as the reference category in the calculation of prevalence ratios. The prevalence of spina bifida and, particularly, anencephaly were lower post-fortification than pre-fortification among both live births and stillbirths (Table 2). Although we found the prevalence of encephalocele among stillbirths to be higher post-fortification than pre-fortification, this defect was only reported for 39 stillbirths.
Table 2

Prevalence of anencephaly, encephalocele and spina bifida before and after mandatory folic acid fortification of flour, Brazil, 2001–2014

Type of birth defectPre-fortificationa
Post-fortificationb
Prevalence change, %
No. of casesPrevalence, cases per 1000 birthsNo. of casesPrevalence, cases per 1000 births
Live births
Anencephaly10350.2120630.16−24.2
Encephalocele3880.088710.07−14.6
Spina bifida14000.2828320.22−23.1
Stillbirths
Anencephaly105616.22132210.19−37.2
Encephalocele390.60950.7322.3
Spina bifida801.231230.95−22.8
All births
Anencephaly20910.4233850.26−38.3
Encephalocele4270.099660.07−13.7
Spina bifida14800.3029550.23−23.8

a The pre-fortification study period ran from 1 January 2001 to 31 December 2004 – although fortification became mandatory in June 2014. We analysed the data for 4 938 343 live births and 65 121 still births that occurred during this period.

b The post-fortification study period ran from 1 January 2005 to 31 December 2014. We analysed the data for 12 987 386 live births and 129 737 still births that occurred during this period.

a The pre-fortification study period ran from 1 January 2001 to 31 December 2004 – although fortification became mandatory in June 2014. We analysed the data for 4 938 343 live births and 65 121 still births that occurred during this period. b The post-fortification study period ran from 1 January 2005 to 31 December 2014. We analysed the data for 12 987 386 live births and 129 737 still births that occurred during this period. The apparent effects of maternal age and sex and race of the child on the prevalence of neural tube defects are summarized in Table 3. In the pre-fortification study period, compared with mothers aged 20–34 years, adolescents were 34% more likely to give birth to a still or liveborn child with a neural tube defect. In the same period, there appeared to be a 40% higher probability of a neural tube defect in a female neonate or stillbirth than in a male one. Although, pre-fortification, the prevalence of neural tube defects was higher among indigenous neonates than among black, brown or white neonates, the differences in prevalence between black, brown and indigenous neonates were not statistically significant – probably because relatively few indigenous neonates were included in our analyses. Folic acid fortification appears to have lowered the prevalence of neural tube defects by 37.7% among the offspring of adolescent mothers and by 36.5% among female neonates and stillbirths.
Table 3

Neonatal and maternal characteristics and the prevalence of neural tube defects before and after mandatory folic acid fortification of flour, Brazil, 2001–2014

CharacteristicPre-fortificationa
Post-fortificationb
Prevalence change %
No. of births (% of total)No. of NTDPrevalence
No. of births (% of total)No. of NTDPrevalence
NTD per 1000 birthsRatio (95% CI)NTD per 1000 birthsRatio (95% CI)
Maternal age, years c
< 20971 805 (19.5)9150.941.34 (1.2–1.4)2 221 078 (17.0)1 3020.591.13 (1.1–1.2)–37.7
20–34d3 488 203 (70.0)2 4490.7019 232 150 (70.5)4 7800.521–26.3
> 34526 589 (10.6)3710.701.00 (0.9–1.1)1 640 707 (12.5)9380.571.10 (1.0–1.2)–18.9
Total4 986 597 (100.0)13 093 935 (100.0)
Sex of neonate or stillbirthe
Female2 437 225 (48.8)2 2640.931.44 (1.3–1.5)6 393 203 (48.8)3 7690.591.18 (1.1–1.2)–36.5
Malef2 560 657 (51.2)1 6560.6516 718 656 (51.2)3 3680.501–22.5
Total4 997 882 (100.0)13 111 859 (100.0)
Race of neonateg
White3 505 035 (77.4)1 9830.571.1 (1.0–1.2)8 730 308 (69.4)3 8950.451.05 (1.0–1.1)–21.1
Brown h880 425 (19.5)4390.5013 347 507 (26.6)1 4220.421–14.8
Black122 622 (2.7)730.601.2 (0.9–1.5)454 023 (3.6)2040.451.06 (0.8–1.3)–24.5
Indigenous15 930 (0.3)130.821.6 (0.9–2.8)41 980 (0.3)210.501.18 (0.8–1.8)–38.7
Total4 524 012 (100.0)12 573 818 (100.0)

CI: confidence interval; NTD: neural tube defects.

a The pre-fortification study period ran from 1 January 2001 to 31 December 2004 – although fortification became mandatory in June 2014.

b The post-fortification study period ran from 1 January 2005 to 31 December 2014.

c Maternal age was missing in 0.22% of the records.

d Used as the reference category in the calculation of prevalence ratios for maternal age.

e Sex of neonate or stillbirth was missing in 0.06% of the records.

f Used as the reference category in the calculation of prevalence ratios for sex of neonate or stillbirth.

g As no data on race were available for stillbirths, the data reported for race refer only to live births.

h Used as the reference category in the calculation of prevalence ratios for race of neonate.

CI: confidence interval; NTD: neural tube defects. a The pre-fortification study period ran from 1 January 2001 to 31 December 2004 – although fortification became mandatory in June 2014. b The post-fortification study period ran from 1 January 2005 to 31 December 2014. c Maternal age was missing in 0.22% of the records. d Used as the reference category in the calculation of prevalence ratios for maternal age. e Sex of neonate or stillbirth was missing in 0.06% of the records. f Used as the reference category in the calculation of prevalence ratios for sex of neonate or stillbirth. g As no data on race were available for stillbirths, the data reported for race refer only to live births. h Used as the reference category in the calculation of prevalence ratios for race of neonate. Although the pre-fortification and post-fortification study subjects were similar in terms of the sex distribution of the neonates or stillbirths, they differed slightly in terms of maternal age and neonatal race (Table 3).

Discussion

Our finding of a decreased prevalence of neural tube defects after mandatory fortification of flour with folic acid confirms observations made in two previous Brazilian studies., One study investigated births in 19 hospitals that together represented 1% of all births in Brazil, and found a reduction in prevalence of 22.1% – from 1.04/1000 births pre-fortification to 0.81/1000 births post-fortification. The other study compared the prevalence of spina bifida in live births for one year pre-fortification and one year post-fortification, and reported a 39.1% reduction; 0.23/1000 to 0.14/1000 births. This study, however, included data from states where a substantial proportion of births are not recorded in the live birth database. Our study covers a longer period, a higher proportion of Brazilian births and all common forms of neural tube defects. The reduction that we observed in the prevalence of neural tube defects in Brazil is higher than the corresponding reduction reported in the USA (19%), very similar to the reduction observed in South Africa (30.5%) and lower than the reductions reported in Chile (40%), Canada (46%) and – for anencephaly and spina bifida only – Argentina (58–60%). A meta-analysis of eight population-based studies on the fortification of flour or other foodstuffs with folic acid estimated the mean reduction in the prevalence of neural tube defects to be 46%. Although 78 countries have now made fortification of some foodstuffs with folic acid mandatory, only five have evaluated the effectiveness of such an intervention in the improvement of health outcomes. In our study, anencephaly was the most common type of neural tube defect, followed by spina bifida and then encephalocele. Although spina bifida has often been reported as the most common form of defect – followed by anencephaly and then encephalocele. Earlier reports on this topic have focused on live births whereas we investigated neural tube defects in both live births and stillbirths. It appears that, in Brazil at least, spina bifida occurs more frequently in stillbirths than in live births. The use of data from live births alone may lead to underestimates in the overall prevalence of neural tube defects., As seen in this and other studies,,– neural tube defects occur more often among female neonates and stillbirths than among males. Although the link between such defects and sex is probably complex, a female fetus requires more human chorionic gonadotropin than a male fetus and deficiencies in this hormone can increase the risk of neural tube defects. The neural tube closes in the first four weeks of embryonic development – i.e. well before the concentration of human chorionic gonadotropin in the fetus peaks on days 40–50 post-fertilization., In the present study, the prevalence of neural tube defects was found to be highest among indigenous neonates, closely followed by black neonates – although it should be noted that there were relatively few birth or death records of indigenous neonates. A study in Canada also found that the risk of neural tube defects was highest among indigenous neonates. Researchers in the USA found that the risk of neural tube defects in pregnancy was twice as high for women of Mexican descent than for white women. The effect of maternal age on the risk of neural tube defects is generally considered to be small. When any such association is observed, the prevalence of neural tube defects tends to be relatively high among those born to mothers in the youngest and oldest age groups. It is possible that the diets of adolescent mothers fail to satisfy the combined nutrient requirements for the growth of both the mother and her fetus. Another possibility is that, compared with older women, adolescent women are less likely to take supplements that contain folic acid. It remains unclear why older mothers might be at relatively high risk of giving birth to a child with a neural tube defect. The public reporting of health data allows health planners to take evidence-informed policy decisions and helps foster a culture of accountability, transparency and efficiency., The relative completeness and reliability of Brazil’s live birth database and mortality information database were essential to the success of our study. Although the public reporting of demographic and health-care data in Brazil began in the 1970s, it was only after the implementation of the national public health system in the mid-1980s that the Brazilian Ministry of Health and other investigators concentrated efforts to guarantee the quality of the data being collected. There has been much evidence of the success of these efforts,,– including the results of a case–control study and active searches for unreported births and deaths., In 2010, the United Nations Children’s Fund acknowledged the political commitment to improving the health information systems in Brazil, especially those recording data on births and infant deaths. Brazil’s health information systems are now in line with the World Health Organization’s push towards evidence-informed policy. A possible source of bias in this study is the termination of pregnancy when the fetus is found to be anencephalic. Although abortion is illegal in Brazil, individual court rulings may override the law. However, there is so much bureaucracy involved in such cases that few abortions are permitted. We were unable to investigate – or control for – the effects of birth order, which is not recorded in either of the information systems we used. We assumed that children born in the second trimester of 2004 would not have benefited from maternal consumption of flour fortified with folic acid. It remains possible that some of these children did benefit but this would indicate that the benefits of fortification were even greater than those we presented.

Conclusion

Our results show that the introduction of the mandatory fortification of flour with folic acid in Brazil was followed by a significant reduction in the incidence of neural tube defects in the centre, south-east and south of the country.
  32 in total

Review 1.  Effects and safety of periconceptional folate supplementation for preventing birth defects.

Authors:  Luz Maria De-Regil; Ana C Fernández-Gaxiola; Therese Dowswell; Juan Pablo Peña-Rosas
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

2.  [Neural tube defects and congenital hydrocephalus. Why is prevalence important?].

Authors:  Eugênio Grillo; Ronaldo José Melo da Silva
Journal:  J Pediatr (Rio J)       Date:  2003 Mar-Apr       Impact factor: 2.197

3.  Translating research into action: WHO evidence-informed guidelines for safe and effective micronutrient interventions.

Authors:  Juan Pablo Pena-Rosas; Luz Maria De-Regil; Lisa M Rogers; Ameya Bopardikar; Ulysses Panisset
Journal:  J Nutr       Date:  2011-11-23       Impact factor: 4.798

4.  Epidemiologic aspects of neural tube defects in South East Iran.

Authors:  Mohammad Afshar; Mohammad J Golalipour; Dariush Farhud
Journal:  Neurosciences (Riyadh)       Date:  2006-10       Impact factor: 0.906

5.  [Validation of birth certificates based on data from a case-control study].

Authors:  Márcia Furquim de Almeida; Gizelton Pereira Alencar; Ivan França; Hillegonda Maria Dutilh Novaes; Arnaldo Augusto Franco de Siqueira; Daniela Schoeps; Oona Campbell; Laura Cunha Rodrigues
Journal:  Cad Saude Publica       Date:  2006-03-27       Impact factor: 1.632

6.  Effects of folic acid fortification on spina bifida prevalence in Brazil.

Authors:  Iêda Maria Orioli; Ricardo Lima do Nascimento; Jorge Santiago López-Camelo; Eduardo Enrique Castilla
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-05-31

7.  [Prevalence and spatial distribution of neural tube defects in São Paulo State, Brazil, before and after folic acid flour fortification].

Authors:  Elizabeth Fujimori; Camila Florido Baldino; Ana Paula Sayuri Sato; Ana Luiza Vilela Borges; Murilo Novaes Gomes
Journal:  Cad Saude Publica       Date:  2013-01       Impact factor: 1.632

8.  Congenital malformations of the central nervous system in spontaneous abortions.

Authors:  M R Creasy; E D Alberman
Journal:  J Med Genet       Date:  1976-02       Impact factor: 6.318

9.  Reduction in neural-tube defects after folic acid fortification in Canada.

Authors:  Philippe De Wals; Fassiatou Tairou; Margot I Van Allen; Soo-Hong Uh; R Brian Lowry; Barbara Sibbald; Jane A Evans; Michiel C Van den Hof; Pamela Zimmer; Marian Crowley; Bridget Fernandez; Nora S Lee; Theophile Niyonsenga
Journal:  N Engl J Med       Date:  2007-07-12       Impact factor: 91.245

Review 10.  Epidemiology of neural tube defects.

Authors:  Lauren Frey; W Allen Hauser
Journal:  Epilepsia       Date:  2003       Impact factor: 5.864

View more
  11 in total

1.  Trends and characteristics of fetal and neonatal mortality due to congenital anomalies, Colombia 1999-2008.

Authors:  Claudia Patricia Roncancio; Sandra Patricia Misnaza; Isabel Cristina Peña; Franklyn Edwin Prieto; Michael J Cannon; Diana Valencia
Journal:  J Matern Fetal Neonatal Med       Date:  2017-05-22

2.  Folate and vitamin B12 status: temporal evaluation after mandatory fortification in Brazil.

Authors:  Cecília Zanin Palchetti; Josiane Steluti; Cristiane Hermes Sales; Regina Mara Fisberg; Dirce Maria Lobo Marchioni
Journal:  Eur J Clin Nutr       Date:  2022-03-22       Impact factor: 4.884

3.  Neural Tube Defects and Associated Factors among Neonates Admitted to the Neonatal Intensive Care Units in Hiwot Fana Specialized University Hospital, Harar, Ethiopia.

Authors:  Yunus Edris; Hanan Abdurahman; Assefa Desalew; Fitsum Weldegebreal
Journal:  Glob Pediatr Health       Date:  2020-11-13

4.  Prevalence of inadequate intake of folate after mandatory fortification: results from the first National Dietary Survey in Brazil.

Authors:  Cecília Zanin Palchetti; Josiane Steluti; Eliseu Verly; Rosangela A Pereira; Rosely Sichieri; Dirce Maria Lobo Marchioni
Journal:  Eur J Nutr       Date:  2019-10-31       Impact factor: 5.614

Review 5.  Closing in on Mechanisms of Open Neural Tube Defects.

Authors:  Sangmoon Lee; Joseph G Gleeson
Journal:  Trends Neurosci       Date:  2020-05-15       Impact factor: 13.837

Review 6.  Nutrition, One-Carbon Metabolism and Neural Tube Defects: A Review.

Authors:  Kelei Li; Mark L Wahlqvist; Duo Li
Journal:  Nutrients       Date:  2016-11-23       Impact factor: 5.717

7.  Neural tube defects: Sex ratio changes after fortification with folic acid.

Authors:  Fernando A Poletta; Monica Rittler; Cesar Saleme; Hebe Campaña; Juan A Gili; Mariela S Pawluk; Lucas G Gimenez; Viviana R Cosentino; Eduardo E Castilla; Jorge S López-Camelo
Journal:  PLoS One       Date:  2018-03-14       Impact factor: 3.240

8.  Improved micronutrient status and health outcomes in low- and middle-income countries following large-scale fortification: evidence from a systematic review and meta-analysis.

Authors:  Emily C Keats; Lynnette M Neufeld; Greg S Garrett; Mduduzi N N Mbuya; Zulfiqar A Bhutta
Journal:  Am J Clin Nutr       Date:  2019-06-01       Impact factor: 7.045

9.  Incidence of neural tube defects and their risk factors within a cohort of Moroccan newborn infants.

Authors:  Khenata Forci; El Arbi Bouaiti; Mohamed Hassan Alami; Asmaa Mdaghri Alaoui; Amal Thimou Izgua
Journal:  BMC Pediatr       Date:  2021-03-15       Impact factor: 2.125

10.  Dolutegravir and pregnancy outcomes in women on antiretroviral therapy in Brazil: a retrospective national cohort study.

Authors:  Gerson Fernando Mendes Pereira; Ahra Kim; Emilia M Jalil; Fernanda Fernandes Fonseca; Bryan E Shepherd; Valdilea G Veloso; Fernanda Rick; Rachel Ribeiro; Maria Cristina Pimenta; Andrea Beber; Renato Girade Corrêa; Renato Lima; Fernanda Maruri; Catherine C McGowan; Adele Schwartz Benzaken; Beatriz Grinsztejn; Jessica L Castilho
Journal:  Lancet HIV       Date:  2021-01       Impact factor: 12.767

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.